Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

被引：1
|
作者：
Karim, N. [1 ]
Pathrose, J. [2 ]
Fathallah, H. [1 ]
El Desouki, I. [1 ]
Perry, A. [1 ]
Starnes, S. [3 ]
Morris, J. [1 ]
机构：
[1] Univ Cincinnati, Internal Med, Cincinnati, OH USA
[2] Univ Cincinnati, Mcmicken Coll Arts & Sci 1, Cincinnati, OH USA
[3] Univ Cincinnati, Surg, Cincinnati, OH USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2018.08.1184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-129
引用
收藏
页码：S714 / S715
页数：2
相关论文
共 50 条
  • [21] MOLECULAR TESTING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER AND THE ROLE OF LIQUID CYTOLOGY SPECIMENS
    Moore, S.
    Loff, K.
    Murphy, M.
    RESPIROLOGY, 2020, 25 : 60 - 60
  • [22] TIMELY REIMBURSEMENT: THE IMPACT OF EARLY ACCESS PROGRAMMES IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Webb, S.
    Mercure, J.
    VALUE IN HEALTH, 2023, 26 (12) : S263 - S263
  • [23] Interlaboratory Variation in Molecular Testing (EGFR, KRAS and ALK) in Stage IV Non-Squamous Non-Small Cell Lung Cancer in the Netherlands in 2013
    Kuijpers, Chantal
    Overbeek, Lucy
    Rottevee, Sandra
    Van Ommen, Rene
    Koole, Koos
    Van Slooten, Henk-Jan
    Van den Heuvel, Michel
    Damhuis, Ronald
    Willems, Stefan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S489 - S490
  • [24] Interlaboratory variation in molecular testing for EGFR, KRAS and ALK in stage IV non-squamous non-small cell lung cancer in The Netherlands in 2013
    Kuijpers, C.
    Overbeek, L.
    Rotteveel, S.
    van Ommen, R.
    Koole, K.
    van Slooten, H. -J.
    van den Heuvel, M.
    Damhuis, R.
    Willems, S.
    VIRCHOWS ARCHIV, 2016, 469 : S194 - S194
  • [25] Specific Adverse Effects of Bevacizumab in the Treatment of Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice
    Mazilu, Laura
    Stanculeanu, Dana Lucia
    Gheorghe, Andreea Daniela
    Suceveanu, Adrian Paul
    Hainarosie, Razvan
    Parepa, Irinel Raluca
    Bratu, Ovidiu
    Diaconu, Camelia Cristina
    Manuc, Daniela
    Stoian, Anca Pantea
    Suceveanu, Andra Iulia
    REVISTA DE CHIMIE, 2018, 69 (12): : 3644 - 3647
  • [26] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Molecular profiling of non-small cell lung cancer
    Gibault, L.
    Cazes, A.
    Narjoz, C.
    Blons, H.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2014, 70 (1-2) : 47 - 62
  • [28] Molecular Profiling in Non-Small Cell Lung Cancer
    Raparia, Kirtee
    Villa, Celina
    DeCamp, Malcolm M.
    Patel, Jyoti D.
    Mehta, Minesh P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (04) : 481 - 491
  • [29] Molecular profiling of non-small cell lung cancer
    Forsythe, Marika L.
    Alwithenani, Akram
    Bethune, Drew
    Castonguay, Mathieu
    Drucker, Arik
    Flowerdew, Gordon
    French, Daniel
    Fris, John
    Greer, Wenda
    Henteleff, Harry
    MacNeil, Mary
    Marignani, Paola
    Morzycki, Wojciech
    Plourde, Madeleine
    Snow, Stephanie
    Xu, Zhaolin
    PLOS ONE, 2020, 15 (08):
  • [30] Adequacy of tissue sampling for molecular profiling in non-small cell lung cancer (NSCLC)
    Gleeson, M.
    O'Callaghan, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (SUPPL 10) : 273 - 274
12345